+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Cardiopulmonary Autotransfusion Systems Market by Product, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6010717
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Cardiopulmonary Autotransfusion Systems Market grew from USD 566.62 million in 2023 to USD 581.63 million in 2024. It is expected to continue growing at a CAGR of 2.83%, reaching USD 689.31 million by 2030.

Cardiopulmonary autotransfusion systems, pivotal in minimizing blood loss during surgical procedures, recycle a patient's own blood, thus reducing dependency on external donor blood supplies. These systems are especially crucial in surgeries with anticipated high blood loss, such as cardiac, trauma, and orthopedic surgeries. Their application in the medical field extends to acting as a risk mitigator for transfusion-related infections and immune reactions. The end-use scope spans hospitals, ambulatory surgical centers, and specialized clinics, aligning with the increasing prevalence of surgical procedures globally. The market is driven by factors such as the rising incidence of chronic diseases necessitating surgical intervention, technological advancements in surgical techniques, and an increasing focus on patient safety. Additionally, an aging population contributes to market demand as older adults often require more surgical interventions. Recent advances in automation and miniaturization present opportunities for innovation, with a focus on developing compact and efficient systems that support minimally invasive surgical practices. Furthermore, emerging markets in Asia-Pacific and Latin America offer potential growth opportunities due to better healthcare access and infrastructure development. However, challenges such as high initial costs, the need for skilled personnel for operation, and a lack of awareness in developing regions impede market expansion. Regulatory barriers and stringent medical device approval processes also pose significant challenges. Innovation should focus on enhancing user-friendliness, affordability, and integration with other surgical technologies to capture untapped markets. Continued research into improving the efficacy and safety of these systems will be vital for business growth. The cardiopulmonary autotransfusion system market is dynamic, with a strong push towards sustainable healthcare solutions and enhancing operational efficiencies, positioning itself as an integral component of modern surgical care landscapes.

Understanding Market Dynamics in the Cardiopulmonary Autotransfusion Systems Market

The Cardiopulmonary Autotransfusion Systems Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing aging population and increase in number of cardiac surgeries
    • Rising healthcare expenditure and advancements in surgical procedures
    • Increasing demand for blood conservation
  • Market Restraints
    • High cost of the system and operational complexity
  • Market Opportunities
    • Technological advancements in the cardiopulmonary autotransfusion systems
    • Innovations in the blood processing techniques and advanced filtration systems
  • Market Challenges
    • Concerns associated with infection risks and contamination issues

Exploring Porter’s Five Forces for the Cardiopulmonary Autotransfusion Systems Market

Porter’s Five Forces framework further strengthens the insights of the Cardiopulmonary Autotransfusion Systems Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Cardiopulmonary Autotransfusion Systems Market

External macro-environmental factors deeply influence the performance of the Cardiopulmonary Autotransfusion Systems Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Cardiopulmonary Autotransfusion Systems Market

The Cardiopulmonary Autotransfusion Systems Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Cardiopulmonary Autotransfusion Systems Market

The Cardiopulmonary Autotransfusion Systems Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Cardiopulmonary Autotransfusion Systems Market

The Cardiopulmonary Autotransfusion Systems Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiopulmonary Autotransfusion Systems Market, highlighting leading vendors and their innovative profiles. These include Advancis Surgical, Becton, Dickinson and Company, Beijing ZKSK Technology Co., Ltd., Braile Biomédica, Brightwake Ltd., Fresenius Kabi, Getinge AB, Global Blood Resources, LLC, LivaNova International, Medtronic PLC, ProCell Surgical, SARSTEDT, Stryker Corporation, Teleflex Incorporated, Terumo Interventional Systems, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Cardiopulmonary Autotransfusion Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Off-Pump Transfusion Device
    • On-Pump Transfusion Device
  • Application
    • Cardiac Surgery
    • Organ Transplant
    • Orthopedic Surgery
    • Trauma Procedures
  • End User
    • Ambulatory Surgical Centers
    • Cardiac Research Centers
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing aging population and increase in number of cardiac surgeries
5.1.1.2. Rising healthcare expenditure and advancements in surgical procedures
5.1.1.3. Increasing demand for blood conservation
5.1.2. Restraints
5.1.2.1. High cost of the system and operational complexity
5.1.3. Opportunities
5.1.3.1. Technological advancements in the cardiopulmonary autotransfusion systems
5.1.3.2. Innovations in the blood processing techniques and advanced filtration systems
5.1.4. Challenges
5.1.4.1. Concerns associated with infection risks and contamination issues
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Cardiopulmonary Autotransfusion Systems Market, by Product
6.1. Introduction
6.2. Off-Pump Transfusion Device
6.3. On-Pump Transfusion Device
7. Cardiopulmonary Autotransfusion Systems Market, by Application
7.1. Introduction
7.2. Cardiac Surgery
7.3. Organ Transplant
7.4. Orthopedic Surgery
7.5. Trauma Procedures
8. Cardiopulmonary Autotransfusion Systems Market, by End User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Cardiac Research Centers
8.4. Hospitals
9. Americas Cardiopulmonary Autotransfusion Systems Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Cardiopulmonary Autotransfusion Systems Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Cardiopulmonary Autotransfusion Systems Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
LIST OF FIGURES
FIGURE 1. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET RESEARCH PROCESS
FIGURE 2. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
TABLE 1. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET DYNAMICS
TABLE 7. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY OFF-PUMP TRANSFUSION DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY ON-PUMP TRANSFUSION DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CARDIAC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY ORGAN TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY TRAUMA PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CARDIAC RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 29. CANADA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 30. CANADA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. CANADA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 32. MEXICO CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 33. MEXICO CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. MEXICO CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. CHINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. CHINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. CHINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. INDIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. INDIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. INDIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. JAPAN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. JAPAN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. JAPAN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. THAILAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. THAILAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. THAILAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 83. DENMARK CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. DENMARK CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. DENMARK CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. EGYPT CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. EGYPT CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. EGYPT CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. FINLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. FINLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. FINLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. FRANCE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. FRANCE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. FRANCE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. GERMANY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. GERMANY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. GERMANY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. ITALY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. ITALY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. ITALY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. NORWAY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. NORWAY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. NORWAY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. POLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. POLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. POLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. QATAR CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. QATAR CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. QATAR CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. SPAIN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. SPAIN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. SPAIN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. TURKEY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. TURKEY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. TURKEY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 147. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Cardiopulmonary Autotransfusion Systems market, which are profiled in this report, include:
  • Advancis Surgical
  • Becton, Dickinson and Company
  • Beijing ZKSK Technology Co., Ltd.
  • Braile Biomédica
  • Brightwake Ltd.
  • Fresenius Kabi
  • Getinge AB
  • Global Blood Resources, LLC
  • LivaNova International
  • Medtronic PLC
  • ProCell Surgical
  • SARSTEDT
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Interventional Systems
  • Zimmer Biomet Holdings, Inc.

Methodology

Loading
LOADING...

Table Information